AI assistant
Medtronic plc — Director's Dealing 2019
Jun 7, 2019
29841_dirs_2019-06-07_f586ce07-12c1-442c-9a5e-680193241611.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2019-06-06
Reporting Person: Martha Geoffrey (EVP & GroupPres Restora Therap)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-06-06 | Ordinary Shares | S | 11000 | $96.053 | Disposed | 48918 | Direct |
Footnotes
F1: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $95.75 to $96.45, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F2: This balance increased by 716 shares due to exempt transactions such as dividend reinvestment.